Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conjugated estrogen versus vaginal sildenafil for thin endometrium in IVF patients
IRCT20220314054278N1Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of sildenafil, conjugated estrogens and estradiol valerate in Endometrial hypotrophy (2 arms), sponsored by Urmia University of Medical Sciences. Primary endpoints: Effect of vaginal sildenafil on endometrial thickness and Uterine endometrial thickness comparison between groups. Started Mar 2022; status: completed.
02
Drugs
sildenafilconjugated estrogensestradiol valerate
03
Conditions
Endometrial hypotrophy
Beyond the preview
Go deeper on IRCT20220314054278N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220314054278N1.